SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
(Amendment No. 2)
Tender Offer Statement under Section 14(d)(1) or
13(e)(1)
of the Securities Exchange Act of 1934
COMPOSECURE HOLDINGS, L.L.C.
(Name of Subject Company and Filing Person (Issuer))
COMPOSECURE, INC.
(Name of Subject Company and Filing Person (Affiliate of Issuer))
7.00% Exchangeable Senior Notes due 2026
(Title of Class of Securities)
20459XAA9
(CUSIP Number of Class of Securities)
Steven J. Feder
General Counsel
CompoSecure, Inc.
309 Pierce Street
Somerset, New Jersey 08873
(908) 518-0500
(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)
With a copy to:
John C. Kennedy, Esq.
Tim Cruickshank, Esq.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, New York 10019
(212) 373-3000
October 9, 2024
(Date Tender Offer First Published, Sent or Given to Security Holders)
¨ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
¨ | third-party tender offer subject to Rule 14d-1. |
x | issuer tender offer subject to Rule 13e-4. |
¨ | going-private transaction subject to Rule 13e-3. |
¨ | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: ¨
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
¨ | Rule 13e-4(i) (Cross-Border Issuer Tender Offer) |
¨ | Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) |
Introduction
This Amendment No. 2 (“Amendment No. 2”) amends and supplements the Tender Offer Statement on Schedule TO initially filed by CompoSecure, Inc. (“Parent”) and CompoSecure Holdings, L.L.C. (the “Company”) on October 9, 2024, as subsequently amended and supplemented by Amendment No. 1 filed on October 28, 2024 (as so amended, this “Schedule TO”) with respect to the Fundamental Change Repurchase Right of each holder of the Company’s 7.00% Exchangeable Senior Notes due 2026 (the “Notes”) pursuant to Section 15.01(c) of the Indenture, dated as of December 27, 2021 (the “Indenture”), by and among the Company, Parent and U.S. Bank National Association, as trustee (the “Trustee”).
Except as otherwise set forth in this Amendment No. 2, the information set forth in the Schedule TO and the related Fundamental Change Company Notice remains unchanged and is incorporated herein by reference to the extent relevant to the items in this Amendment. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule TO.
Item 11. Additional Information.
Item 11 of the Schedule TO is hereby amended and supplemented to include the following information:
The Fundamental Change Repurchase Right expired at 5:00 p.m., New York City time, on Wednesday, November 27, 2024. Parent and the Company were advised by U.S. Bank National Association, as paying agent and exchange agent for the Notes, that, as of the expiration time, no Notes were surrendered for repurchase pursuant to Holders’ Fundamental Change Repurchase Right. Pursuant to the terms of the Indenture, 100% of the outstanding Notes were validly exchanged for shares of Parent’s Class A Common Stock prior to the Fundamental Change Expiration Date. As of the date of this Amendment No. 2, there were no Notes outstanding.
2
SIGNATURES
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
CompoSecure, Inc. | |||
By: | /s/ Steven J. Feder | ||
Name: | Steven J. Feder | ||
Title: | General Counsel & Corporate Secretary | ||
CompoSecure Holdings, L.L.C. | |||
By: | /s/ Steven J. Feder | ||
Name: | Steven J. Feder | ||
Title: | Secretary | ||
Date: December 5, 2024 |
EXHIBIT INDEX
* Previously Filed
3